Average Co-Inventor Count = 2.79
ph-index = 15
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. University of Pennsylvania (161 from 2,551 patents)
2. Inovio Pharmaceuticals, Inc. (53 from 86 patents)
3. The Wistar Institute of Anatomy & Biology (32 from 157 patents)
4. The Wistar Institute (10 from 84 patents)
5. Other (3 from 832,347 patents)
6. Apollon, Inc. (2 from 13 patents)
7. Trustees of the University of Pennslyvania (2 from 10 patents)
8. Valorisation-recherche, Societe En Commandite (2 from 5 patents)
9. Bp Corporation North America Inc. (1 from 492 patents)
10. Colorado State University Research Foundation (1 from 466 patents)
11. Philadelphia Health and Education Corporation (1 from 52 patents)
12. Vgx Pharmaceuticals, Inc. (1 from 18 patents)
13. Institut De Recherches Cliniques De Montreal (1 from 11 patents)
14. Cargill Inc. (854 patents)
15. Drexel University (603 patents)
185 patents:
1. 12419945 - Vaccines against Zika virus
2. 12390521 - Canine distemper vaccines and methods of treatment using the same
3. 12357683 - Vaccines against Nipah virus, and methods of using same
4. 12296001 - DNA vaccine against crimean-congo hemorrhagic fever virus (CCHFV)
5. 12280108 - Vaccines having an antigen and interleukin-21 as an adjuvant
6. 12268735 - consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of using same
7. 12240872 - Filovirus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of using same
8. 12195536 - DNA monoclonal antibodies targeting CTLA-4 for the treatment and prevention of cancer
9. 12194086 - Mayaro virus consensus antigens, DNA antibody constructs for use against Mayaro virus, and combinations thereof
10. 12194000 - Optimized synthetic consensus immunogenic compositions targeting chondroitin sulfate proteoglycan 4 (CSPG4)
11. 12162925 - DNA-encoded monoclonal antibodies targeting the Ebolavirus glycoprotein
12. 12110342 - Nucleic acid monoclonal antibodies targeting PCSK9 and methods of use
13. 12109258 - Synthetic malaria immunogens, combinations thereof, and their use to prevent and treat malaria infections
14. 12054537 - Optimized nucleic acid antibody constructs encoding anti-respiratory syncytial virus (RSV) antibodies
15. 12049479 - Foot and mouth disease virus (FMDV) consensus proteins, coding sequences therefor and vaccines made therefrom